Medicare Drug Plans and Eli Lilly's $50 Cap Controversy
Eli Lilly has reported that certain basic Medicare drug plans might not adopt the $50 monthly cap on out-of-pocket costs for its weight-loss medications. This development arises despite the Medicare agency's coverage model designed to regulate these expenses.